This compound is an N-oxide derivative of alprazolam, characterized by a triazolobenzodiazepine core with a chlorine substituent and an N-oxide functional group. It is primarily identified as an active pharmaceutical ingredient impurity, relevant to quality control and impurity profiling in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 30896-65-2
Secobarbital sodium
pharmaceutical raw material
Flupentixol decanoate
pharmaceutical raw material
MIDODRINE HYDROCHLORIDE
pharmaceutical raw material
Doxifluridine
pharmaceutical raw material
8-chloro-1-methyl-5-oxido-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-5-ium
WHYAIKHHRCPZBI-UHFFFAOYSA-N
CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=[N+](C2)[O-])C4=CC=CC=C4